Your browser is no longer supported. Please, upgrade your browser.
DCTH Delcath Systems, Inc. weekly Stock Chart
DCTH [NASD]
Delcath Systems, Inc.
Index- P/E- EPS (ttm)-8.98 Insider Own0.10% Shs Outstand188.00M Perf Week222.58%
Market Cap30.08M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float167.76M Perf Month589.66%
Income-27.50M PEG- EPS next Q- Inst Own1.60% Short Float10.25% Perf Quarter77.78%
Sales2.40M P/S12.53 EPS this Y27.20% Inst Trans222.40% Short Ratio0.27 Perf Half Y-85.84%
Book/sh-0.01 P/B- EPS next Y- ROA-76.00% Target Price16.00 Perf Year-96.18%
Cash/sh0.03 P/C4.70 EPS next 5Y15.00% ROE- 52W Range0.01 - 6.49 Perf YTD-82.61%
Dividend- P/FCF- EPS past 5Y42.90% ROI-139.30% 52W High-97.53% Beta1.07
Dividend %- Quick Ratio0.90 Sales past 5Y- Gross Margin72.20% 52W Low966.67% ATR0.05
Employees43 Current Ratio1.00 Sales Q/Q75.00% Oper. Margin- RSI (14)61.40 Volatility86.66% 49.24%
OptionableNo Debt/Eq- EPS Q/Q79.80% Profit Margin- Rel Volume3.98 Prev Close0.24
ShortableYes LT Debt/Eq- EarningsMay 03 BMO Payout- Avg Volume63.99M Price0.16
Recom2.00 SMA20128.41% SMA50178.76% SMA200-84.73% Volume254,575,432 Change-32.26%
Jun-08-10Initiated BioLogic Equity Research Sell
Apr-22-10Reiterated Wedbush Outperform $7.50 → $21
Apr-22-10Initiated Roth Capital Buy $15
Nov-30-09Initiated Wedbush Morgan Outperform
Jun-10-08Initiated Canaccord Adams Buy $2.65
Jun-05-17 05:15PM  Delcath Systems, Inc. Announces Adjournment of Annual Meeting Meeting Scheduled to Reconvene on June 16 GlobeNewswire +15.00%
May-09-17 08:00AM  Delcath Announces First Quarter 2017 Financial Results GlobeNewswire
Apr-27-17 08:00AM  Delcath Issues Letter to Stockholders GlobeNewswire
Apr-18-17 08:00AM  Spire Southampton Hospital in UK Celebrating Over 100 CHEMOSAT Treatments GlobeNewswire +19.32%
Apr-03-17 08:17AM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibi -5.59%
Apr-01-17 01:04PM  DELCATH SYSTEMS, INC. Financials
Mar-29-17 08:00AM  Delcath Announces 2016 Financial Results GlobeNewswire -9.90%
06:08AM  DELCATH SYSTEMS, INC. Files SEC form 10-K, Annual Report
Mar-27-17 12:40PM  Delcath Clinical Study Design Approved By FDA Investopedia +13.33%
12:40PM  Delcath Clinical Study Design Approved By FDA at Investopedia
08:00AM  Delcath Announces Special Protocol Assessment Agreement With FDA for Pivotal Trial With Melphalan/HDS in Intrahepatic Cholangiocarcinoma GlobeNewswire
Mar-10-17 08:30AM  Delcath Systems To Present At ROTH Capital Partners 29th Annual Growth Stock Conference On March 13, 2017 GlobeNewswire
Feb-23-17 08:04AM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events -9.82%
Feb-22-17 04:28PM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Change in Directors or Principal Officers +10.76%
08:00AM  Published Review Shows Delcath Investigational PHP Doubles Overall Survival Over Other Targeted Liver Therapies GlobeNewswire
Feb-21-17 08:00AM  Analysis From Two Institutions Shows Strong Tumor Response, Overall Survival Potential of Delcath Investigational PHP Therapy GlobeNewswire +7.59%
Feb-15-17 08:42AM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits -21.20%
Feb-06-17 10:30AM  Delcath Systems to Present at the 2nd Annual Disruptive Growth & Healthcare Conference Accesswire -5.46%
Jan-30-17 12:26PM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-26-17 08:59AM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events -10.24%
Jan-23-17 08:00AM  Delcath Systems To Present At The NobleCon13 - Noble Capital Markets' Thirteenth Annual Investor Conference On January 31, 2017 PR Newswire
Jan-18-17 08:00AM  New Outcomes Data Using Delcath's Melphalan/HDS To Treat Unresectable Metastatic Ocular Melanoma To The Liver Accepted For Oral Presentation At Regional Cancer Therapies Symposium PR Newswire -14.43%
Jan-12-17 08:30AM  Delcath Announces Ongoing Patient Treatment And Data Collection In Intrahepatic Cholangiocarcinoma Study Cohort PR Newswire +8.40%
Jan-06-17 04:04PM  DryShips, Merrimack Tumble into Fridays 52-Week Low Club -29.34%
Nov-30-16 08:30AM  Delcath Systems to Present at the 9th Annual LD Micro Main Event Accesswire
Nov-14-16 12:27PM  Delcath Systems, Inc. :DCTH-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016 +6.42%
Nov-11-16 07:30AM  Delcath Announces Third Quarter Financial Results PR Newswire +15.43%
Nov-10-16 04:42PM  DELCATH SYSTEMS, INC. Files SEC form 10-Q, Quarterly Report +7.64%
Oct-18-16 04:32PM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  Delcath Issues Letter to Stockholders PR Newswire
Oct-17-16 08:30AM  Review Of Delcath's CHEMOSAT Accepted For Publication In Advances In Therapy PR Newswire
Oct-12-16 09:08AM  Delcath Announces First European Clinical Sites For FOCUS Phase 3 Trial For Ocular Melanoma Liver Metastases PR Newswire
Oct-11-16 08:57AM  Delcath Announces New U.S. Clinical Sites For FOCUS Phase 3 Trial For Ocular Melanoma Liver Metastases PR Newswire
Oct-05-16 04:36PM  Delcath To Present At The Dawson James Securities Growth Stock Conference PR Newswire +7.06%
Oct-04-16 08:43AM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Finan
Sep-30-16 12:50PM  Heres Why These Five Stocks Are on the Move Today at Insider Monkey -28.26%
09:22AM  Delcath Prices Underwritten Public Offering of Common Stock and Warrants Business Wire
Sep-29-16 05:40PM  Delcath Announces Proposed Public Offering of Common Stock and Warrants PR Newswire
Sep-19-16 09:50AM  Delcath Sponsors Ocular Melanoma Foundation Patient Retreat PR Newswire -6.26%
Sep-14-16 08:30AM  Data Supporting CHEMOSAT Presented at the Cardiovascular and Interventional Radiology Society of Europe Conference Business Wire
Sep-12-16 04:05PM  Delcath To Present At The 2016 Aegis Growth Conference PR Newswire
08:42AM  Researchers at leiden univeristy medical center receive outstanding service award for Publication on Delcath's Melphalan/HDS PR Newswire
Aug-18-16 10:44AM  Delcath Systems, Inc. :DCTH-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016
Aug-16-16 08:00AM  Delcath Announces Second Quarter Financial Results PR Newswire
Aug-15-16 04:11PM  DELCATH SYSTEMS, INC. Files SEC form 10-Q, Quarterly Report
Aug-08-16 04:09PM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Other Events -7.76%
Jul-21-16 06:04AM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. o -18.45%
Jul-18-16 08:00AM  Delcath Announces Acceptance Of Abstracts For Poster Presentation At CIRSE 2016 PR Newswire
Jul-07-16 08:00AM  Outcomes Study On Delcath's Melphalan/HDS In The Treatment Of Hepatic Metastases To Be Published In Cancer Control PR Newswire
Jul-06-16 08:00AM  European Data Supporting Survival Benefit With Delcath's CHEMOSAT System Presented At 6th European Post-Chicago Melanoma/Skin Cancer Meeting PR Newswire +7.10%
Jun-23-16 08:00AM  Delcath European Patient Education Website Receives Prestigious Digital Health Award PR Newswire
Jun-17-16 04:17PM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Bal
Jun-15-16 08:00AM  Delcath Announces Acceptance Of Abstract For Presentation At 6th European Post-Chicago Melanoma/Skin Cancer Meeting PR Newswire +6.69%
Jun-07-16 08:31AM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stateme -20.91%
08:00AM  Delcath Issues $35 Million in Senior Convertible Notes to Support Melphalan/HDS Clinical Development and CHEMOSAT European Commercialization PR Newswire
Jun-01-16 08:00AM  Delcath Announces Launch of CHEMOSAT at the HM Sanchinarro University Hospital in Madrid PR Newswire
May-31-16 08:00AM  Delcath to Present at the 6th Annual LD Micro Invitational PR Newswire
May-26-16 11:17AM  Delcath Systems, Inc. :DCTH-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016
May-04-16 05:09PM  DELCATH SYSTEMS, INC. Files SEC form 10-Q, Quarterly Report -6.25%
08:00AM  Delcath Announces First Quarter Financial Results PR Newswire
May-03-16 08:00AM  Leading U.S. Cancer Centers Join Delcath's Focus Phase 3 Trial For Patients With Hepatic Dominant Ocular Melanoma PR Newswire +6.63%
Apr-08-16 08:00AM  Delcath Announces First CHEMOSAT® Procedures In Turkey PR Newswire +9.19%
Apr-07-16 04:17PM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Mar-23-16 04:34PM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
10:37AM  Delcath Systems, Inc. :DCTH-US: Earnings Analysis: Q4, 2015 By the Numbers
Mar-22-16 02:20PM  Delcath Systems, Inc. :DCTH-US: Earnings Analysis: 2015 By the Numbers
Mar-21-16 08:18AM  Delcath Announces 2015 Fourth Quarter and Full Year Financial Results at noodls
08:00AM  Delcath Announces 2015 Fourth Quarter and Full Year Financial Results PR Newswire
Mar-18-16 02:12PM  DELCATH SYSTEMS, INC. Files SEC form 10-K, Annual Report -5.12%
Mar-07-16 08:00AM  Delcath to Present at the 28th Annual ROTH Conference PR Newswire
Feb-11-16 08:30AM  Delcath announces Engagement of Lars E. Birgerson, M.D., Ph. D as global medical consultant PR Newswire
Feb-10-16 04:22PM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stand +6.72%
08:30AM  Delcath Announces Beginning Of Patient Enrollment In Phase 3 Focus Trial PR Newswire
Feb-04-16 08:00AM  Delcath Systems to Present at Upcoming Investor Conferences PR Newswire
Jan-22-16 04:26PM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-20-16 08:00AM  Delcath Announces Initiation Of Phase 3 Trial Of Melphalan/HDS System For Treatment Of Hepatic Dominant Ocular Melanoma PR Newswire -8.70%
Jan-19-16 08:00AM  MicroCap Review Magazine Winter/Spring 2016 Issue Now Available Marketwired
08:00AM  Delcath Announces Special Protocol Assessment Agreement With FDA For New Phase 3 Trial In Hepatic Dominant Ocular Melanoma PR Newswire
Jan-15-16 10:17AM  Delcath To Present At NobleCon12 Investor Conference PR Newswire
Jan-11-16 08:30AM  Review of Delcath Melphalan/HDS System Published in "Cardiovascular & Interventional Radiology" PR Newswire
Dec-09-15 08:59AM  Delcath Prior Phase 3 Trial Results Published In Annals Of Surgical Oncology PR Newswire +14.14%
Dec-08-15 08:00AM  Delcath Announces CHEMOSAT Review Accepted for Publication in Cardiovascular and Interventional Radiology PR Newswire
Dec-02-15 08:00AM  Delcath Announces CHEMOSAT Treatment Milestones In Europe PR Newswire -6.04%
Nov-25-15 04:07PM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Nov-17-15 10:00AM  Delcath Systems Inc Conference Call to discuss Business Update scheduled for 10:00 am ET today -9.73%
Nov-11-15 09:40AM  Delcath Systems To Host Business Update Conference Call On November 17, 2015 PR Newswire
Nov-10-15 04:10PM  DELCATH SYSTEMS, INC. Files SEC form 10-Q, Quarterly Report
08:30AM  Delcath Reports 2015 Third Quarter Financial Results PR Newswire
Nov-02-15 08:30AM  Data Supporting Delcath's CHEMOSAT System Presented At The European Association Of Dermato Oncology Annual Congress PR Newswire
Oct-15-15 05:02PM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Change in Directors or Principal Officers +10.91%
11:07AM  Delcath Announces First Patient Treated In ICC Cohort Of Global Phase 2 HCC Trial Program PR Newswire
Oct-14-15 08:00AM  Delcath Phase 3 Trial Results To Be Published In Annals Of Surgical Oncology PR Newswire +5.35%
Oct-09-15 04:53PM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +19.60%
08:30AM  StockNewsNow.com Publishes New SNNLive Video Interview With Delcath Systems, Inc. Marketwired
Oct-08-15 08:30AM  Delcath Announces National Reimbursement Coverage For CHEMOSAT Procedures In Germany PR Newswire +5.42%
Oct-06-15 04:21PM  DELCATH SYSTEMS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit
08:00AM  Delcath Systems Appoints CEO Jennifer Simpson To Board Of Directors PR Newswire
Oct-02-15 10:51AM  Delcath Systems, Inc. Earnings Q2, 2015
Sep-30-15 08:00AM  Data Supporting Delcath's Chemosat System Presented At The Cardiovascular and Interventional Radiology Society Annual Meeting PR Newswire
Sep-28-15 08:00AM  Retrospective Study Examining Delcath's CHEMOSAT And Isolated Hepatic Perfusion Presented At ECCO Annual Meeting PR Newswire -13.65%
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers. The company is developing melphalan hydrochloride for Injection for use with the Delcath hepatic delivery system to administer high-dose chemotherapy to the liver. It offers melphalan hydrochloride under the Delcath Hepatic CHEMOSAT Delivery System for Melphalan name in Europe. The company was founded in 1988 and is headquartered in New York, New York.